Oncology / Cancer Research

Partners relies upon the Dana Farber Cancer Institute (DFCI) IRBs for the review and approval of adult and pediatric oncology treatment research protocols and selected adult non-treatment oncology research protocols under the terms and conditions outlined in an Agreement executed by the three parties (BWH, DFCI, and MGH). Because of this agreement, Partners investigators would complete the DFCI forms and submit to the DFCI IRBs.

Selected oncology research protocols may be reviewed by the Partners IRBs if the research is conducted solely at the BWH or MGH. If this is the case, then the Partners investigator can submit their protocol to the Partners IRBs using Insight/eIRB. NOTE: The DFCI IRB does not use Insight/eIRB to receive submissions.

In either case, BWH / MGH investigators and staff conducting research are subject to the Harvard Faculty of Medicine Conflict of Interest Policy and/or Partners Conflicts of Interest Policy, and sponsored research involving BWH and MGH investigators is reviewed by Partners CARL and/or Grants and Contracts. For questions, contact Maria Sundquist at the Partners Human Research Office.